📰 Primary Relief News
Primary Relief News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Relief. Real-time updates on events, politics, business and more.
October 20, 2022
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.
September 27, 2022
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
September 22, 2022
/PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been approved to treat pain following...
August 9, 2022
The FDA has cleared Primary Relief, a percutaneous electrical neurostimulation device, for symptomatic relief of postoperative pain following C-section delivery.
July 28, 2022
/PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been clearedto treat pain following a...
July 28, 2022
The FDA has cleared Primary Relief, a percutaneous electrical neurostimulation device, for symptomatic relief of postoperative pain following C-section delivery.
July 14, 2022
/PRNewswire/ -- First Relief, a PENS (percutaneous electrical neurostimulation) device, has been cleared by the US Food and Drug Administration for multiple...